RISEDRONAT TEVA 35 MG TBL FLM 12

What is the maximum co-payment for RISEDRONAT TEVA?

If the insurance company contributes, the maximum co-payment is 0,00 Kč. The maximum pharmacy price is 401,30 Kč. A pharmacy may provide the medicine for a lower price, but not for a higher price.

Does the medicine have reimbursement from public health insurance?

Yes, but the reimbursement conditions (reporting limit) have not been set.

Does RISEDRONAT TEVA have a counted co-payment set?

No, this medicine has no counted co-payment.

How much does the insurance company pay for one dispensed reimbursed pack?

431,92 Kč.

Does the insurance company pay a higher amount in some cases?

No, the medicine has no increased reimbursement.

Does the medicine have an indication restriction?

Kyselina alendronová, risedronová a ibandronová (o síle 150 mg v jedné tabletě) jsou hrazeny pacientům s osteoporózou prokázanou celotělovým denzitometrem (T-skóre méně než -2,5 SD) nebo osteoporotickou patologickou zlomeninou. Léčba je dlouhodobá, trvá nejméně dva roky. Terapie delší než dva roky je hrazena pouze u nemocných s prokazatelnou zástavou úbytku kostní hmoty.

Is it available without a medical prescription?

No, the medicine cannot be obtained without a prescription.

Which medical specialist may prescribe RISEDRONAT TEVA?

Prescription is not conditional on a medical specialization.

What is the composition of RISEDRONAT TEVA?

Natrium-risedronát (35 mg), kyselina risedronová (32,5 mg), monohydrát laktosy, kukuřičný škrob, neznámá látka s kódem 4989, koloidní bezvodý oxid křemičitý, neznámá látka s kódem 4174, magnesium-stearát, polyvinylalkohol, oxid titaničitý, neznámá látka s kódem 4077, ointmentek, žlutý oxid železitý, červený oxid železitý. More information about the composition can be found in the SPC, section 6.1.